ZFAND3 and pancreatic adenocarcinoma: Pan-tumor studies based on TCGA and GTEx databases (via GEPIA platform)25,26 also highlighted increased ZFAND3 expression in diverse cancers compared to control tissue, in particular in pancreatic adenocarcinoma and melanoma (Supplementary Fig. 2g).